Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18–49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY). - Hammitt, Laura L; Quinn, Dean; Janczewska, Ewa; Pasquel, Francisco J; Tytus, Richard; Reddy, K Rajender; Abarca, Katia; Khaertynova, Ilsiyar M; Dagan, Ron; McCauley, Jennifer; Cheon, Kyeongmi; Pedley, Alison; et al. (Open Forum Infectious Diseases, 2022)